Results 1 to 10 of about 108,615 (251)

Resurrecting Epstein–Barr Virus

Pathogens, 2022
One of the Editor’s choice articles in 2021 published in Pathogens was an early assessment of the role of Epstein–Barr virus (EBV) reactivation in the pathogenesis of long-term symptoms associated with COVID-19 [...]
Roberto Paganelli
doaj   +3 more sources

Epstein–Barr Virus (EBV) Genotypes Associated with the Immunopathological Profile of People Living with HIV-1: Immunological Aspects of Primary EBV Infection

Viruses, 2022
Background: The aim of the present study was to evaluate the immunological profile of adult HIV-1+ patients coinfected with primary Epstein–Barr virus (EBV) infection who were free of antiretroviral drugs and inhabitants of the Brazilian Amazon region ...
Leonn Mendes Soares Pereira, Eliane dos Santos França, Iran Barros Costa, Igor Tenório Lima, Amaury Bentes Cunha Freire, Francisco Lúzio de Paula Ramos, Talita Antonia Furtado Monteiro, Olinda Macedo, Rita Catarina Medeiros Sousa, Felipe Bonfim Freitas, Igor Brasil Costa, Antonio Carlos Rosário Vallinoto   +11 more
doaj   +1 more source

HLA-B*13, B*35 and B*39 Alleles Are Closely Associated With the Lack of Response to ART in HIV Infection: A Cohort Study in a Population of Northern Brazil

Frontiers in Immunology, 2022
IntroductionImmune reconstitution failure after HIV treatment is a multifactorial phenomenon that may also be associated with a single polymorphism of human leukocyte antigen (HLA); however, few reports include patients from the Brazilian Amazon.
Leonn Mendes Soares Pereira, Eliane dos Santos França, Iran Barros Costa, Erika Vanessa Oliveira Jorge, Patrícia Jeanne de Souza Mendonça Mattos, Amaury Bentes Cunha Freire, Francisco Lúzio de Paula Ramos, Talita Antonia Furtado Monteiro, Olinda Macedo, Rita Catarina Medeiros Sousa, Rita Catarina Medeiros Sousa, Eduardo José Melo dos Santos, Eduardo José Melo dos Santos, Felipe Bonfim Freitas, Igor Brasil Costa, Igor Brasil Costa, Antonio Carlos Rosário Vallinoto, Antonio Carlos Rosário Vallinoto   +17 more
doaj   +1 more source

Epidemiological risk factors associated with primary infection by Epstein–Barr virus in HIV-1-positive subjects in the Brazilian Amazon region

Scientific Reports, 2021
To identify the prevalence and risk factors for primary Epstein–Barr virus (EBV) infection in human immunodeficiency virus (HIV)-1-positive adult treatment-naïve patients between January 2018 and December 2019 in a state of the Brazilian Amazon region. A
Leonn Mendes Soares Pereira, Eliane dos Santos França, Iran Barros Costa, Igor Tenório Lima, Amaury Bentes Cunha Freire, Francisco Lúzio de Paula Ramos, Talita Antonia Furtado Monteiro, Olinda Macedo, Rita Catarina Medeiros Sousa, Felipe Bonfim Freitas, Igor Brasil Costa, Antonio Carlos Rosário Vallinoto   +11 more
doaj   +1 more source

Evaluation of plasma Epstein–Barr virus DNA as a biomarker for Epstein–Barr virus–associated Hodgkin lymphoma

SAGE Open Medicine, 2021
Objectives: Epstein–Barr virus is a tumorigenic virus and has been extensively studied as a causative agent for Hodgkin lymphoma. Although immunostaining of the tumor biopsy is the standard method for diagnosis of Epstein–Barr virus-driven Hodgkin ...
Masuma Khatun Usha, Jasmine Akhter Jahan, SM Rashed Ul Islam, Ferdousy Begum, Chowdhury Rafiqul Ahsan, Mahmuda Yasmin   +5 more
doaj   +1 more source

Epstein-Barr virus infection and sporadic breast cancer risk: a meta-analysis. [PDF]

PLoS ONE, 2012
BACKGROUND: A large number of epidemiological studies have evaluated the association between Epstein-Barr virus infection and breast carcinoma risk but results have been inconsistent.
Qiang Huo, Ning Zhang, Qifeng Yang
doaj   +1 more source

Antibodies Against Epstein–Barr Virus as Disease Markers of Gastric Cancer: A Systematic Review

Technology in Cancer Research & Treatment, 2023
Introduction: Gastric cancer is the fourth deadliest cancer worldwide. Due to the lack of specific early symptoms and noninvasive methods for early detection, the prognosis of gastric cancer patients is poor.
José I. Fontes-Lemus BSc, Isaac Zhao MSc, Charles S. Rabkin MD, Ezequiel M. Fuentes-Pananá PhD   +3 more
doaj   +1 more source

Epstein-Barr Virus

Microbiology Spectrum, 2016
ABSTRACT This review covers relevant clinical and laboratory information relating to Epstein-Barr virus (EBV) infections in immunocompromised hosts. It describes the epidemiology and clinical manifestations with a primary focus on disease in solid organ and stem cell transplant recipients.
Andrew, Nowalk, Michael, Green
openaire   +2 more sources

Co-expression of Epstein–Barr virus–encoded RNA1 and viral latent membrane protein 1 in osteosarcoma: A novel insight of predictive markers

Tumor Biology, 2020
Epstein–Barr virus is an etiologic agent of several malignancies. In this study, we explored the association of Epstein–Barr virus–encoded RNA1 and Epstein–Barr virus latent membrane protein 1 co-expression with osteosarcoma.
Keykhosro Mardanpour, Mahtab Rahbar, Sourena Mardanpour, Sidegheh Khazaei, Mansour Rezaei   +4 more
doaj   +1 more source

Epstein–Barr virus vaccines [PDF]

Clinical & Translational Immunology, 2015
Epstein–Barr virus (EBV) is the primary cause of infectious mononucleosis (IM) and is associated with epithelial cell malignancies such as nasopharyngeal carcinoma and gastric carcinoma, as well as lymphoid malignancies including Hodgkin lymphoma, Burkitt lymphoma, non‐Hodgkin lymphoma and post‐transplant lymphoproliferative disorder.
openaire   +3 more sources